Nuveen’s Ionis Pharmaceuticals IONS Stock Holding History

Nuveen’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$48.7M	Sell	648,496 -12,273	-2%	-$969K	0.01%	662
2025 Q4	$52.3M	Buy	660,769 +245,151	+59%	+$18.5M	0.01%	619
2025 Q3	$27.2M	Buy	415,618 +170,533	+70%	+$8.33M	0.01%	953
2025 Q2	$9.68M	Sell	245,085 -63,692	-21%	-$2.08M	﹤0.01%	1525
2025 Q1	$9.32M	Buy	308,777 +17,823	+6%	+$584K	﹤0.01%	1592
2024 Q4	$10.2M	Sell	290,954 -13,825	-5%	-$517K	﹤0.01%	1594
2024 Q3	$12.2M	Sell	304,779 -105,625	-26%	-$4.91M	﹤0.01%	1488
2024 Q2	$19.6M	Sell	410,404 -12,626	-3%	-$518K	0.01%	1146
2024 Q1	$18.3M	Buy	423,030 +99,024	+31%	+$4.72M	0.01%	1234
2023 Q4	$16.4M	Buy	324,006 +14,862	+5%	+$712K	0.01%	1283
2023 Q3	$14M	Sell	309,144 -32,307	-9%	-$1.33M	﹤0.01%	1270
2023 Q2	$14M	Buy	341,451 +27,586	+9%	+$1.06M	﹤0.01%	1306
2023 Q1	$11.2M	Sell	313,865 -9,313	-3%	-$350K	﹤0.01%	1411
2022 Q4	$12.2M	Sell	323,178 -16,106	-5%	-$677K	﹤0.01%	1361
2022 Q3	$15M	Sell	339,284 -9,402	-3%	-$396K	0.01%	1209
2022 Q2	$12.9M	Buy	348,686 +32,867	+10%	+$1.24M	0.01%	1353
2022 Q1	$11M	Sell	315,819 -35,657	-10%	-$1.17M	﹤0.01%	1577
2021 Q4	$10.7M	Sell	351,476 -277,000	-44%	-$8.72M	﹤0.01%	1646
2021 Q3	$21.1M	Sell	628,476 -94,625	-13%	-$3.57M	0.01%	1237
2021 Q2	$28.8M	Sell	723,101 -226,136	-24%	-$8.86M	0.01%	1095
2021 Q1	$42.7M	Buy	949,237 +330,826	+53%	+$18.5M	0.01%	806
2020 Q4	$35M	Buy	618,411 +191,513	+45%	+$9.54M	0.01%	895
2020 Q3	$20.3M	Sell	426,898 -51,403	-11%	-$2.86M	0.01%	1056
2020 Q2	$28.2M	Buy	478,301 +1,074	+0.2%	+$59.7K	0.01%	829
2020 Q1	$22.6M	Buy	477,227 +68	+0%	+$3.79K	0.01%	845
2019 Q4	$28.8M	Sell	477,159 -22,028	-4%	-$1.31M	0.01%	966
2019 Q3	$29.9M	Buy	499,187 +16,278	+3%	+$1.06M	0.01%	921
2019 Q2	$31M	Buy	482,909 +470,539	+3,804%	+$33.3M	0.01%	920
2019 Q1	$1M	Buy	12,370 +800	+7%	+$51.6K	0.01%	743
2018 Q4	$625K	Buy	+11,570	New	+$590K	﹤0.01%	787
2018 Q3	–	Sell	-11,153	Closed	-$465K	–	1056
2018 Q2	$465K	Hold	11,153	–	–	﹤0.01%	881
2018 Q1	$492K	Sell	11,153 -22,000	-66%	-$1.12M	﹤0.01%	891
2017 Q4	$1.67M	Sell	33,153 -15,700	-32%	-$861K	0.01%	634
2017 Q3	$2.48M	Sell	48,853 -20,800	-30%	-$1.09M	0.02%	588
2017 Q2	$3.54M	Sell	69,653 -1,780	-2%	-$82.9K	0.02%	528
2017 Q1	$2.87M	Buy	71,433 +48,400	+210%	+$2.17M	0.02%	604
2016 Q4	$1.1M	Hold	23,033	–	–	0.01%	1115
2016 Q3	$844K	Hold	23,033	–	–	﹤0.01%	1130
2016 Q2	$536K	Hold	23,033	–	–	﹤0.01%	1161
2016 Q1	$933	Buy	23,033 +12,581	+120%	+$511K	﹤0.01%	1045
2015 Q4	$647	Hold	10,452	–	–	﹤0.01%	1215
2015 Q3	$422	Sell	10,452 -51	-0.5%	-$2.64K	﹤0.01%	1363
2015 Q2	$605	Sell	10,503 -42,597	-80%	-$2.71M	﹤0.01%	1312
2015 Q1	$3.38M	Sell	53,100 -142,046	-73%	-$9.64M	0.02%	631
2014 Q4	$12M	Sell	195,146 -56,175	-22%	-$2.77M	0.07%	350
2014 Q3	$9.76M	Sell	251,321 -215,132	-46%	-$7.62M	0.06%	384
2014 Q2	$16.1M	Buy	466,453 +10,341	+2%	+$326K	0.1%	275
2014 Q1	$19.7M	Buy	456,112 +133,740	+41%	+$6.48M	0.12%	233
2013 Q4	$12.8M	Buy	322,372 +181,750	+129%	+$6.48M	0.08%	308
2013 Q3	$5.28M	Buy	140,622 +46,234	+49%	+$1.38M	0.03%	515
2013 Q2	$2.54M	Buy	+94,388	New	+$2.01M	0.02%	678

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen's IONS Position: Q1 2026 in Review

Nuveen reduced its Ionis Pharmaceuticals (IONS) stake by 1.9% in Q1 2026, selling an estimated $969K and leaving 648,496 shares worth $48.7M. The position accounts for 0.01% of the portfolio, ranked #662.

Nuveen first reported a position in IONS in Q2 2013 and has held it in 51 quarters since. The position peaked at $52.3M in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

Nuveen held 648,496 shares of Ionis Pharmaceuticals worth $48.7M as of Q1 2026.
Nuveen sold 12,273 Ionis Pharmaceuticals shares in Q1 2026, an estimated $969K.
Ionis Pharmaceuticals made up 0.01% of Nuveen's portfolio in Q1 2026, its #662 holding.
Nuveen first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
Nuveen's Ionis Pharmaceuticals position peaked at $52.3M in Q4 2025.
493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.